Latest Feature

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Kimberly-Clark readies Halyard Health medical device spinout

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

GI Dynamics proposes 1-for-10 reverse stock split

October 21, 2014 by Val Kennedy

GI Dynamics shareholders are slated to vote on whether to approve a 1-for-10 reverse stock split in an effort to raise the company's lagging share price.

GI Dynamics proposes 1-for-10 reverse stock split

Intuitive Surgical shows improvement despite profit decline

October 21, 2014 by MassDevice

Intuitive Surgical jumps in after-hours trading on better-than-expected 2nd-quarter sales and earnings, raised lower end of revenues outlook.

Intuitive Surgical shows improvement despite profit decline

Allergan says it stands by statements on Valeant

October 21, 2014 by MassDevice

Allergan says there's no evidence to back claims by hostile suitors Valeant Pharmaceuticals and hedge mogul William Ackman's Pershing Square Capital Management that Allergan CEO David Pyott led a smear campaign against them.

Allergan says it stands by statements on Valeant

MassDevice.com +3 | The top 3 medtech stories for October 21, 2014

October 21, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Boston Scientific wins CE Mark, FDA nod for spinal surgical leads

October 21, 2014 by Brad Perriello

Boston Scientific says its CoverEdge 32 and CoverEdge X 32 surgical leads won CE Mark approval in the European Union and pre-market approval from the FDA for use with its Precision Spectra spinal cord stimulator.

Boston Scientific wins CE Mark, FDA nod for spinal surgical leads

Sensory Medical raises $1.4m for Relaxis restless legs treatment

October 21, 2014 by Alexander Soule

Sensory Medical announces a $1.4 million tranche in a funding round for its Relaxis device to relieve symptoms of restless legs syndrome.

Sensory Medical raises $1.4m for restless-leg treatment

Sensory Medical shook a leg on a 2nd tranche of funding since receiving FDA clearance last spring for its device to relieve symptoms of restless legs syndrome, reporting $1.4 million in fresh funding on the heels of a $1 million tranche in June.

Medrobotics taps backers for $20m

October 21, 2014 by Alexander Soule

Medrobotics closes $20 million in new funding as it gear up to commercialize its robot-assisted flexible endoscope in Europe.

Medrobotics taps markets for $20m

Medrobotics said it closed on $20 million in new funding in a preferred stock sale to prior backers as plans to expand its commercial footprint in Europe.

Raynham, Mass.-based Medrobotics also said that it's "met all applicable FDA requirements" to distribute its Flex Retractor in the U.S.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp